低聚原花青素通过抑制TLR 4/NF-κB通路对糖尿病肾病大鼠的肾脏保护和炎症抑制作用

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1890 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To study the effect of oligomeric procyanidins on renal function protection and inflammation inhibition in diabetic kidney disease rats by inhibiting TLR 4/NF- κB pathway. Methods DKD rat models were established by intraperitoneal injection of streptozotocin (50 mg/kg) and high fat and high sugar diet, and then, low-, medium- and high- doses of OPC (125, 250 and 500 mg/kg) were administered orally to treat DKD rats. After 8 weeks, the blood glucose level, renal index, urinary microalbumin, blood urea nitrogen, and blood creatinine were measured. The levels of IL-1β, IL-6 and MCP-1in serum and renal cortex were detected by ELISA kit. The protein level of TLR 4/NF- κ B related were measured by Western blot. Results Compared with the model group, the pathological state of glomeruli in the low-, middle- and high-dose group of OPC was significantly improved. The fasting blood glucose, renal index, urine albumin protein, serum creatinine and blood urea nitrogen levels of the rats in the medium dose and high dose OPC groups were significantly lower than those in the model group (P<0.05) . The levels of IL-1β, IL-6 and MCP-1 were significantly lower than those in the model group (P<0.05). The result of western blot analysis showed that compared with the model group, the protein level of TLR4 and ratio of p-IκBα/IκBα of rats in OPC medium dose group and OPC high dose group decreased significantly (P<0.05). Conclusions OPC can inhibit TLR 4/NF- κ B pathway, and reduce renal function damage and inflammatory reaction of DKD rat model.

Key words： oligomeric procyanidins diabetic kidney disease TLR4/NF- κB pathway inflammatory response

Received: 08 December 2022

R587

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	LV Xiaonan
	ZONG Chunhui
	SONG Guangming

Cite this article:

LV Xiaonan,ZONG Chunhui,SONG Guangming. Effects of oligomeric procyanidins on renal function protection and inflammation inhibition in diabetic kidney disease rats by inhibiting TLR 4/NF- κB pathway[J]. Med. J. Chin. Peop. Armed Poli. Forc., 2023, 34(4): 305-309.

URL:

http://journal08.magtechjournal.com/Jwk_wjyx/EN/ OR http://journal08.magtechjournal.com/Jwk_wjyx/EN/Y2023/V34/I4/305

[1]	吴小梅,石彩凤,周阳,等. 2型糖尿病患者生存质量及其与糖尿病肾病发病的关系[J]. 山东医药, 2022, 62(27):77-79.
[2]	Pérez-Morales R E, Del Pino M D, Valdivielso J M, et al. Inflammation in diabetic kidney disease[J].Nephron, 2019, 143(1):12-16.
[3]	郑文, 潘少康, 刘东伟,等. 糖尿病肾病治疗进展[J]. 中华肾脏病杂志, 2020, 36(6):476-480.
[4]	吕晓楠, 董铮, 李春进,等. 低聚原花青素对葡聚糖硫酸钠诱导小鼠溃疡性结肠炎的保护作用[J]. 武警医学, 2020, 31(7), 572-575.
[5]	Rajakumari R, Volova T, Oluwafemi O S, et al. Grape seed extract-soluplus dispersion and its antioxidant activity [J]. Drug Dev Ind Pharm, 2020, 46(8):1219-1229.
[6]	王卫娜. 葡萄籽原花青素对糖尿病大鼠肾脏GLUT2及肾功能的影响[J]. 中医临床研究, 2016, 8(11):10-12.
[7]	Zhou Y, Li B Y, Li X L, et al. Restoration of mimecan expression by grape seed procyanidin B2 through regulation of nuclear factor-kappa B in mice with diabetic nephropathy[J]. Iran J Kidney Dis, 2016, 10(5):325-331.
[8]	邱腾, 王迪. 葡萄籽原花青素对糖尿病大鼠肾缺血再灌注损伤的影响[J]. 中国临床药理学杂志, 2020,36(14):2036-2038.
[9]	吕晓楠, 宗春辉, 董铮. 低聚原花青素对糖尿病肾病大鼠足细胞上皮-间质转化的抑制作用[J]. 武警医学, 2021,32(7): 616-619,622.
[10]	Zhou Y, Ma X Y, Han J Y, et al. Metformin regulates inflammation and fibrosis in diabetic kidney disease through TNC/TLR4/NF-κB/miR-155-5p inflammatory loop[J].World J Diabetes, 2021, 12(1):19-46.
[11]	Hassan H M, Mahran Y F, Ghanim A M H. Ganoderma lucidum ameliorates the diabetic nephropathy via down-regulatory effect on TGFβ-1 and TLR-4/NFκB signalling pathways [J].J Pharm Pharmacol, 2021, 73(9):1250-1261.
[12]	刘晴, 解进, 杜凯,等. 糖尿病肾病的中医药实验研究进展[J]. 天津中医药大学学报, 2022, 41(5):675-680.
[13]	高利超,甘林望,耿磊,等. 低聚原花青素通过介导Wnt/β-catenin信号通路对糖尿病肾病大鼠肾功能的保护作用研究[J]. 中国现代医学杂志,2022,32(10):7-12.
[14]	赵悦,王俭勤. 炎症在糖尿病肾病中的研究进展[J]. 新医学,2021,52(7):477-481.
[15]	张尚维, 李明星, 赵蕊, 等. 糖尿病肾病发生的氧化应激机制及抗氧化治疗的研究进展[J]. 中国药理学与毒理学杂志, 2020, 34(8):76-82.
[16]	张瑞, 李娟, 杲和艳. 西格列汀联合贝那普利对糖尿病肾病患者糖代谢、肾功能、炎症因子指标的影响[J]. 临床医学研究与实践, 2021, 6(36):52-54.
[17]	Wang H Q, Wang S S, Chiufai K, et al. Umbelliferone ameliorates renal function in diabetic nephropathy rats through regulating inflammation and TLR/NF-κB pathway [J]. Chin J Nat Med, 2019, 17(5):346-354.
[18]	Tawfik M K, Keshawy M M, Makary S. Blocking angiotensin 2 receptor attenuates diabetic nephropathy via mitigating ANGPTL2/TL4/NF-κB expression [J]. Mol Biol Rep, 2021, 48(9):6457-6470.
[19]	Podgórski P, Konieczny A, Lis , et al. Glomerular podocytes in diabetic renal disease[J]. Adv Clin Exp Med, 2019, 28(12):1711-1715.
[20]	Lin M, Yiu W H, Wu H J, et al. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy [J].J Am Soc Nephrol, 2012, 23(1):86-102.

[1]	. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2023, 34(2): 180-184.